Skip to main navigation Skip to search Skip to main content

A new furoxan NO-donor rabeprazole derivative and related compounds

  • Giovanni SORBA
  • , Ubaldina GALLI
  • , C. CENA
  • , R. FRUTTERO
  • , A. GASCO
  • , G. MORINI
  • , M. ADAMI
  • , G. CORUZZI
  • , M. I. BRENCIAGLIA
  • , F. DUBINI

Research output: Contribution to journalArticlepeer-review

Abstract

Stomach pump: Gastric antisecretory and protective activity against damaging agents are shown by the pump inhibitor rabeprazole (1). This compound is also potently active against Helicobacter pylori strains that are resistant to metronidazole. Modification of 1 with a furazan or furoxan group significantly reduced its antisecretory potency but not its efficacy. The furoxan analogue, which can act as an NO donor, has a protective activity comparable to that of the parent molecule.

Original languageEnglish
Pages (from-to)899-903
Number of pages5
JournalChemBioChem
Volume4
Publication statusPublished - 2003

Fingerprint

Dive into the research topics of 'A new furoxan NO-donor rabeprazole derivative and related compounds'. Together they form a unique fingerprint.

Cite this